- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Mar 5, 2025
Deals
Chimerix’s alignment with FDA on submission drives $935M takeout by Jazz
Building in oncology, Jazz obtains targeted glioma therapy under FDA review
BioCentury | Mar 6, 2024
Discovery & Translation
Distillery spotlight: new Type II diabetes mechanisms from academia
New targets to drive insulin secretion, islet cell numbers and receptor localization from BioCentury’s survey of the 2023 translational literature
BioCentury | May 31, 2019
Translation in Brief
New target for Oncoceutics' GPCR-targeting compounds
Oncoceutics' compounds increase mitochondrial protease activity to kill cancer
Items per page:
1 - 6 of 6